内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-18 · 构建时间： 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

Immunome Inc.

IMNM · Nasdaq · CIK 0001472012 · Healthcare · Biotechnology

内部人信号

当前没有活跃买入信号

2 qualifying P purchase groups
当前 180 天评分窗口

40 同一窗口内观察到的 Form 4 交易行
21 sales · 15 期权、代扣税、授予、赠与或其他交易行

最近一次合资格买入2026-06-05 · BIENAIME JEAN JACQUES · $204.3K

为什么没有活跃信号？

买入活动存在
近期买入2 qualifying line group(s)
近期卖出High
买入信号状态未激活
评分构成

活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。

Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算

为什么没有分数？

  • 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
  • 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。

卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
Barchas IsaacDirector
▼▼▼▼▼▼▼▼▼
Horn KinneyCHIEF BUSINESS OFFICER
○▼○○▼
Lechleider RobertChief Medical Officer
○▼○▼○
Higgins JackChief Scientific Officer
○○○▼
Rosett MaxChief Financial Officer
○▼○
BIENAIME JEAN JACQUESDirector
●●▼
● 买入▼ 卖出○ 其他

Showing the six most active owners; 3 additional owner(s) remain in Form 4 申报证据.

买方广度与集中度

合资格买方1
买入集中度100%最大买方： BIENAIME JEAN JACQUES · $307.8K
聚集买入 · 15天1 insider峰值活动： 2026-05-15–2026-05-15

Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.

信号历史

暂无已记录的活跃信号快照

Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-06-05 · BIENAIME JEAN JACQUES.

近期 Form 4 活动

11买入
28卖出
19其他 Form 4 交易行
30SEC 申报 · 365天
买入4 qualifying P line(s) · 180 days
卖出21 sale line(s) · 仅供背景
其他15 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

该股票尚未获取市场背景。每日任务会轮转处理美国股票池。

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
16,757,287
上期报告
16,244,557
日均成交量
1,691,367
回补天数
9.9

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2026-06-05BIENAIME JEAN JACQUES买入 (P)Common Stock10,500USD 19.45USD 204,260SEC 申报 ↗
2026-05-15BIENAIME JEAN JACQUES买入 (P)Common Stock5,000USD 20.70USD 103,500SEC 申报 ↗
2026-03-27SIEGALL CLAY B买入 (P)Common Stock25,450USD 19.67USD 500,602SEC 申报 ↗
2026-03-11BIENAIME JEAN JACQUES买入 (P)Common Stock1,000USD 21.55USD 21,550SEC 申报 ↗
2026-03-10BIENAIME JEAN JACQUES买入 (P)Common Stock1,000USD 22.12USD 22,120SEC 申报 ↗
2025-12-30SIEGALL CLAY B买入 (P)Common Stock4,729USD 21.15USD 100,018SEC 申报 ↗
2025-12-19Tsai Philip买入 (P)Common Stock10,000USD 20.49USD 204,900SEC 申报 ↗
2025-12-19SIEGALL CLAY B买入 (P)Common Stock7,278USD 20.48USD 149,053SEC 申报 ↗
2025-12-18SIEGALL CLAY B买入 (P)Common Stock46,511USD 21.50USD 999,986SEC 申报 ↗
2025-06-03BIENAIME JEAN JACQUES买入 (P)Common Stock5,000USD 9.38USD 46,900SEC 申报 ↗
2025-03-26SIEGALL CLAY B买入 (P)Common Stock137,100USD 7.29USD 999,459SEC 申报 ↗
2025-03-25BIENAIME JEAN JACQUES买入 (P)Common Stock7,800USD 7.78USD 60,684SEC 申报 ↗
2025-03-24Tsai Philip买入 (P)Common Stock12,300USD 8.42USD 103,566SEC 申报 ↗
2025-03-24BIENAIME JEAN JACQUES买入 (P)Common Stock7,000USD 8.21USD 57,470SEC 申报 ↗
2025-01-31SIEGALL CLAY B买入 (P)Common Stock150,000USD 7.75USD 1,162,500SEC 申报 ↗

Form 4 申报证据

58 transaction lines in the latest 365-day window; 109 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-09-11Higgins Jack卖出 (S)Common Stock13,200USD 25.32USD 334,224SEC 申报 ↗
2026-09-11Higgins Jack期权行权／转换 (M)Common Stock18,000USD 1.35USD 24,300SEC 申报 ↗
2026-09-11Higgins Jack赠与 (G)Common Stock8,800USD 0.00USD 0SEC 申报 ↗
展开近期 Form 4 证据 (30 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-09-11Higgins Jack卖出 (S)Common Stock13,200USD 25.32USD 334,224SEC 申报 ↗
2026-09-11Higgins Jack期权行权／转换 (M)Common Stock18,000USD 1.35USD 24,300SEC 申报 ↗
2026-09-11Higgins Jack赠与 (G)Common Stock8,800USD 0.00USD 0SEC 申报 ↗
2026-08-12Barchas Isaac卖出 (S)Common Stock11,048USD 27.25USD 301,058SEC 申报 ↗
2026-08-11Barchas Isaac卖出 (S)Common Stock62,291USD 26.23USD 1,633,893SEC 申报 ↗
2026-08-10Barchas Isaac卖出 (S)Common Stock10,125USD 26.07USD 263,959SEC 申报 ↗
2026-08-07Barchas Isaac卖出 (S)Common Stock15,248USD 26.06USD 397,363SEC 申报 ↗
2026-08-06Barchas Isaac卖出 (S)Common Stock20,840USD 26.06USD 543,090SEC 申报 ↗
2026-08-04Horn Kinney卖出 (S)Common Stock90,616USD 25.09USD 2,273,555SEC 申报 ↗
2026-08-04Horn Kinney期权行权／转换 (M)Common Stock90,616USD 11.89USD 1,077,379SEC 申报 ↗
2026-07-23Tsai Philip奖励／授予 (A)Common Stock38,250USD 0.00USD 0SEC 申报 ↗
2026-07-23Stoneman Sandra G.奖励／授予 (A)Common Stock38,250USD 0.00USD 0SEC 申报 ↗
2026-07-23SIEGALL CLAY B奖励／授予 (A)Common Stock180,000USD 0.00USD 0SEC 申报 ↗
2026-07-23Rosett Max奖励／授予 (A)Common Stock47,250USD 0.00USD 0SEC 申报 ↗
2026-07-23Lechleider Robert奖励／授予 (A)Common Stock54,000USD 0.00USD 0SEC 申报 ↗
2026-07-23Horn Kinney奖励／授予 (A)Common Stock31,250USD 0.00USD 0SEC 申报 ↗
2026-07-23Higgins Jack奖励／授予 (A)Common Stock38,250USD 0.00USD 0SEC 申报 ↗
2026-07-07Horn Kinney卖出 (S)Common Stock1,092USD 25.00USD 27,300SEC 申报 ↗
2026-07-07Horn Kinney期权行权／转换 (M)Common Stock1,092USD 12.92USD 14,109SEC 申报 ↗
2026-07-07Barchas Isaac卖出 (S)Common Stock16,906USD 24.20USD 409,125SEC 申报 ↗
2026-07-06Barchas Isaac卖出 (S)Common Stock83,094USD 24.11USD 2,003,396SEC 申报 ↗
2026-07-02Lechleider Robert卖出 (S)Common Stock55,000USD 22.62USD 1,244,331SEC 申报 ↗
2026-07-02Lechleider Robert期权行权／转换 (M)Common Stock55,000USD 8.73USD 480,150SEC 申报 ↗
2026-07-02Barchas Isaac卖出 (S)Common Stock100,000USD 22.59USD 2,258,848SEC 申报 ↗
2026-06-30Barchas Isaac卖出 (S)Common Stock101,050USD 21.12USD 2,134,176SEC 申报 ↗
2026-06-25Lechleider Robert卖出 (S)Common Stock55,000USD 19.85USD 1,091,662SEC 申报 ↗
2026-06-25Lechleider Robert期权行权／转换 (M)Common Stock55,000USD 8.73USD 480,150SEC 申报 ↗
2026-06-15Rosett Max卖出 (S)Common Stock60,000USD 18.23USD 1,093,800SEC 申报 ↗
2026-06-15Rosett Max期权行权／转换 (M)Common Stock60,000USD 1.05USD 63,000SEC 申报 ↗
2026-06-05BIENAIME JEAN JACQUES卖出 (S)Common Stock10,500USD 19.41USD 203,820SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码IMNM
CIK0001472012
行业Healthcare
细分行业Biotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
交易所Nasdaq

数据覆盖

本地 Form 4 历史109 transaction lines from 2020-10-06 to 2026-09-11
42 P purchase lines · 30 S sale lines · 37 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.